Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |